Crystal structure of the IL-22/IL-22R1 complex and its implications for the IL-22 signaling mechanism  by Bleicher, Lucas et al.
FEBS Letters 582 (2008) 2985–2992Crystal structure of the IL-22/IL-22R1 complex and its implications
for the IL-22 signaling mechanism
Lucas Bleichera, Patricia Ribeiro de Mouraa, Leandra Watanabea, Didier Colaub,
Laure Dumoutierb,c, Jean-Christophe Renauldb,c, Igor Polikarpova,*
a Instituto de Fı´sica de Sa˜o Carlos, Universidade de Sa˜o Paulo, Av. Trabalhador Sa˜o-Carlense, 400, CEP 13560-970 Sa˜o Carlos, SP, Brazil
b Ludwig Institute for Cancer Research, Brussels Branch, Belgium
c Experimental Medicine Unit, Christian de Duve Institute, Universite´ Catholique de Louvain, Brussels, Belgium
Received 13 June 2008; revised 2 July 2008; accepted 6 July 2008
Available online 7 August 2008
Edited by Hans EklundAbstract Interleukin-22 (IL-22) is a member of the interleukin-
10 cytokine family, which is involved in anti-microbial defenses,
tissue damage protection and repair, and acute phase responses.
Its signaling mechanism involves the sequential binding of IL-22
to interleukin-22 receptor 1 (IL-22R1), and of this dimer to
interleukin-10 receptor 2 (IL-10R2) extracellular domain. We
report a 1.9 A˚ crystal structure of the IL-22/IL-22R1 complex,
revealing crucial interacting residues at the IL-22/IL-22R1 inter-
face. Functional importance of key residues was conﬁrmed by
site-directed mutagenesis and functional studies. Based on the
X-ray structure of the binary complex, we discuss a molecular
basis of the IL-22/IL-22R1 recognition by IL-10R2.
Structured summary:
MINT-6693956:
Il22 (uniprotkb:Q9GZX6) and IL22R1 (uniprotkb:Q8N6P7)
bind (MI:0407) by X-ray crystallography (MI:0114)
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Interleukin-22 (IL-22) is an inﬂammatory cytokine that is
mainly produced by activated T-cells [1,2]. It was ﬁrst de-
scribed as an IL-9-inducible gene and called IL-TIF (interleu-
kin-10, IL-10-related T-cell derived inducible factor) [1]. IL-22
stimulates the production of acute phase reactants and pro-
motes the antimicrobial defense, what indicates IL-22 involve-
ment in the inﬂammatory and immune responses in several
organs [3,4]. It has been reported that IL-22 can suppress inter-Abbreviations: IL-22R1, interleukin-22 receptor 1; IL-22, interleukin-
22; IL-10, interleukin-10; IL-10R2, interleukin-10 receptor 2; CRF2-9,
cytokine receptor family class 2 member 9; CRF2-4, the second chain
of the IL-10 receptor complex; IL-20, interleukin-20; IL-24, interleu-
kin-24; IL-10R1, interleukin-10 receptor 1; FBN-III, ﬁbronectin-III
domain; IL-4, interleukin-4; IL-4Ra/cc, IL-4 receptor a common c
chain (cc); IL-13Ra1, interleukin-13 receptor a; STAT3, signal
transducer and activator of transcription 3; HEK-293, human embry-
onic kidney 293 cells
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doi:10.1016/j.febslet.2008.07.046leukin-4 (IL-4) production, suggesting that IL-22 may have
therapeutic utility in the treatment of asthma [2].
The crystal structure of recombinant human IL-22 was
determined in 2002 [5], and it consists of a compact bundle
of a single domain composed of six anti-parallel a-helices. Hu-
man IL-22 shares a limited amino acid sequence identity (22%)
with human IL-10, and possesses 179 residues, an N-terminal
hydrophobic signal peptide, two disulﬁde bridges, 20 kDa
in size, and three potential N-linked glycosylation sites [1]. In
2005, the IL-22 crystal structure was determined from insect-
cell expressed protein [6], and no relevant change of the overall
tertiary structure is detected whether glycosylated and non-gly-
cosylated structures are compared.
IL-22 cellular responses require its binding to speciﬁc cell
surface receptors belonging to the class II cytokine receptor
family, as observed in all IL-10 family members [7]. These
two distinct receptor chains are interleukin-22 receptor 1 (IL-
22R1) (cytokine receptor family class 2 member 9, CRF2-9)
and interleukin-10 receptor 2 (IL-10R2) (the second chain of
the IL-10 receptor complex, CRF2-4) [2,4,8], and they are
structurally related to the interleukin-10 receptor 1 (IL-10R1)
receptor chain [3]. IL-22R1 is also able to bind interleukin-
20 (IL-20) and interleukin-24 (IL-24), forming a heterodimer
with IL-20R2 [9], while IL-10R2 is also the second chain of
the IL-10 heterodimeric receptor. There is strong experimental
evidence that IL-22 initially binds IL-22R1 with high aﬃnity,
and then the ternary complex is formed by sequential associa-
tion of the IL-22/IL-22R1 with IL-10R2 [10,11]. The IL-22/IL-
22R1/IL-10R2 ternary complex enables JAK/STAT activation,
which induces the expression of IL-22 speciﬁc genes [1].
So far, no IL-22/IL-22R1/IL-10R2 crystal structure has been
reported and the structural basis of this ternary complex for-
mation remains elusive. Nevertheless, low-resolution struc-
tures of the IL-22/IL-22R1 complex were assessed by small
angle X-ray scattering [12], and the IL-10/IL-10R1/IL-10R2
ternary complex has been generated by homology modeling
[13]. Although experimental data about the interactions be-
tween the IL-22 binary complex and IL-10R2 are scarce, it
has been suggested that IL-22/IL-22R1 complex formation
would lead to conformational changes in IL-22 that would al-
low IL-10R2 binding, and the sequential binding of IL-10R1
would lead to eﬀective signal transduction [10].
Here we report the crystal structure of the IL-22/IL-22R1
binary complex reﬁned to 1.9 A˚ resolution. The three-dimen-
sional structure reveals key residues that are crucial for IL-
22 binding to IL-22R1. We also conducted mutagenesis andblished by Elsevier B.V. All rights reserved.
Table 1
Crystallographic and structural informationa
Data collection parameters
Space group C2
˚
2986 L. Bleicher et al. / FEBS Letters 582 (2008) 2985–2992functional studies to conﬁrm the importance of these residues
for IL-22 binding. Furthermore, based on the X-ray structure
of the binary complex, we propose a plausible model of IL-22/
IL-22R1/IL-10R2 ternary assembly.
Cell parameters (A; ) 49.2, 79.2, 92.0; 90.0, 94.6, 90.0
Wavelength (A˚) 1.5418
Resolution limits (A˚) 50.0–1.90 (1.97–1.90)
Completeness (%) 0.98 (0.95)
Redundancy 2.8 (2.4)
Rmerge (%)
b 10.6 (30.5)
I/r 7.14 (2.82)
Total number of reﬂections 27359
Reﬂections used for reﬁnement/Rfree 25984/1375
Reﬁnement parameters
Bond length mean deviation (A˚) 0.012
Bond angles mean deviation () 1.56
Rfactor (%) 19.0
Rfree (%) 23.4
aValues between parentheses refer to the last resolution shell.
bRmerge ¼
P jI i  hIij=
P
I , where Ii is the intensity of the ith obser-
vation and ÆIæ is the mean intensity of the reﬂections.2. Materials and methods
2.1. Protein expression and puriﬁcation
The recombinant human IL-22 (residues 29–179) and the extracellu-
lar domain of human IL-22R1 (residues 18–228) were expressed in
Escherichia coli and puriﬁed from inclusion bodies, as described previ-
ously [5,12]. The IL-22 receptor complex was formed by overnight
incubation of IL-22 with IL-22R1 in a 1.2:1 molar ratio at 277 K.
The complex was puriﬁed by gel ﬁltration chromatography on a Super-
dex 200 column, and the puriﬁed complex was concentrated to 5 mg/ml
for crystallization trials.
2.2. Crystallization and X-ray data collection
Crystallization experiments were performed at 291 K and employed
the hanging drop vapour diﬀusion method. Brieﬂy, equal amounts of
puriﬁed protein and reservoir solution were mixed and 2 ll-hanging
drops were allowed to equilibrate against the reservoir solution. Suit-
able crystals were obtained after 5 days from solution consisting of
0.9 M sodium acetate, 1 mM Triton X-100 and 0.1 M HEPES at pH
7.5. Prior to data collection, crystals were soaked into a cryo-cooling
solution composed of mother liquor containing 20% (v/v) glycerol,
and ﬂash frozen in a 100 K nitrogen stream in the W01B-MX2 beam
line at Laborato´rio Nacional de Luz Sı´ncrotron. A total of 139 images
were collected using 1 of oscillation step, to a maximum resolution be-
yond 1.9 A˚. The dataset was indexed, reduced, merged and scaled
using HKL2000 [14].2.3. Structure determination and reﬁnement
Successful molecular replacement solutions for both chains (IL-22
and IL-22R1) were possible using the MrBump pipeline [15], Phaser
for molecular replacement [16] and Chainsaw [17] for PDB modiﬁca-
tion. A molecule of IL-22 was easily found in the asymmetrical unit
using the coordinates of hIL-22 (PDB accession code 1M4R, [5]) as
a search model. In the case of IL-22R1, which has no solved structure,
the coordinates of the IL-10R1 receptor (PDB accession code 1J7V,
[18]) were initially used as a search model, but this approach was not
successful. By allowing MrBump to seek for all possible search models
in the PDB, the extracellular domain of human tissue factor (PDB
accession code 1TFH, [19]) was identiﬁed as a reasonable starting
model, and the molecular replacement was accomplished. The reason
for successful molecular replacement using human tissue factor (which
has lower sequence identity with IL-22R1) instead of IL-10R1 is re-
lated to the fact that the angle between the two ﬁbronectin-III domain
(FBN-III) in IL-22R1 is slightly larger than in IL-10R1, leading to a
better Ca–Ca superpositioning, and the poor IL-10R1/IL-22R1
main-chain alignment would compromise the molecular replacement.
The model was reﬁned alternating cycles of model manipulation in
Coot [20] and reﬁnement in Phenix [21]. Stereochemical analysis was
performed with PROCHECK [22]. General information and statistics
for data processing and model reﬁnement are given in Table 1.2.4. IL-22R1 mutagenesis
The IL-22R1 cDNA was ampliﬁed by RT-PCR from the HepG2
hepatoma cell line before cloning into the pEF-BOSpuro expression
vector. Mutagenesis on IL-22R1 was performed by using Quick
Change II XL Site-Directed Mutagenesis kit (Stratagene) with speciﬁc
primers: K58A sense [5 0 GTC TAC AGC ATC GAG TAT GCC
ACG TAC GGA GAG AGG G 3 0] and anti-sense [5 0 CCC TCT
CTC CGT ACG TGG CAT ACT CGA TGC TGT AGA C 3 0];
K58E sense [5 0 ACA CGG TCT ACA GCA TCG AGT ATG AGA
CGT ACG GAG 3 0] and anti-sense [5 0 CTC CGT ACG TCT CAT
ACT CGA TGC TGT AGA CCG TGT 3 0]; Y60A sense [5 0 GCA
TCG AGT ATA AGA CGG CCG GAG AGA GGG ACT GGG
3 0] and anti-sense [5 0 CCC AGT CCC TCT CTC CGG CCG TCT
TAT ACT CGA TGC 3 0]; Y60R sense [5 0 GCA TCG AGT ATA
AGA CGC GCG GAG AGA GGG ACT GGG 3 0] and anti-sense[5 0 CCC AGT CCC TCT CTC CGC GCG TCT TAT ACT CGA
TGC 3 0]. Clones obtained were sequenced by using BigDye Terminator
v.3.1 Ready Reaction (Applied Biosystem).
2.5. Transient cell transfection and luciferase assay
Human embryonic kidney (HEK) 293-EBNA cells were grown in
DMEM medium supplemented with 10% FCS. The pGL3-Pap1 lucif-
erase reporter plasmid was used as a speciﬁc promoter for signal trans-
ducer and activator of transcription 3 (STAT3) activation, whereas the
pRL-TK plasmid (Promega), encoding Renilla luciferase, was co-trans-
fected as an internal control of the transfection process. Transient hu-
man embryonic kidney 293 cells (HEK-293) cell transfections were
carried out as previously described [23]. Brieﬂy, HEK-293-EBNA cells
were seeded in 48-well plates (1 · 105 cells/well) 1 day before transfec-
tion, and all transfections assays were carried out using the Lipofect-
amine 2000 method (Invitrogen), according to the manufacturers
recommendations, and using 250 ng of receptor constructs cDNA,
250 ng of pGL3-Pap1 and 100 ng of pRL-TK vector. After 5 h, trans-
fected cells were stimulated with control medium or with human IL-22
protein for 16 h. Recombinant human IL-22 was produced in E. coli as
previously described [9], and luciferase assays were performed using
the Dual Luciferase Reporter Assay kit (Promega).3. Results and discussion
3.1. Model quality
The IL-22/IL-22R1 complex structure was solved by molec-
ular replacement and reﬁned at 1.9 A˚ resolution to Rfactor of
19.0% and Rfree of 23.4% (Table 1). There is a single IL-22/
IL-22R1 complex in the asymmetric unit cell, resulting in a sol-
vent content of 41.9%. The ﬁnal model of the complex includes
IL-22R1 (residues Asp20 to Thr228) and residues Ala40 to
Ile179 of IL-22, and also 309 water molecules. Polypeptide
fragments 149GDHG and 172NRTY of IL-22R1, and 131TCHI-
EGDDL of IL-22 were not included in the ﬁnal model because
of the poor or disordered electron density. The Ramachandran
plot indicates that a total of 94.5% and 5.5% of the amino acid
residues are in the most favoured and additionally allowed re-
gions, respectively. No residues have been found in the disal-
lowed regions.
3.2. Overall IL-22/IL-22R1 complex structure
Human IL-22 and IL-10 have 22% amino acid sequence
identity (Fig. 1A), bind to diﬀerent high aﬃnity receptors
Fig. 1. Amino acid sequence alignment of human IL-22 and IL-10 (A), and the extracellular domains of human IL-22R1 and IL-10R1 receptor
chains (B). Secondary structure elements are shown in blue. Residues are colored according to their side chain chemical properties: acidic in red,
aliphatic in black and grey (small), amide in green, aromatic in brown, basic in navy, hydroxyl in pink, imino in orange and sulfur in yellow. Sequence
alignments were performed with TEXshade software.
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mon signaling receptor (IL-10R2) for the assembly of their ac-
tive ternary complexes. The IL-22R1, IL-10R1 and IL-10R2
receptor chains all belong to the cytokine receptor family class
2 (CRF-2). The amino acid sequence of extracellular domain
of IL-22R1 has 24% identity with IL-10R1 receptor (Fig. 1B).
The three-dimensional structure of the IL-22/IL-22R1 bin-
ary complex is shown in Fig. 2. IL-22 consists of a compact
bundle of six anti-parallel a-helices (termed A–F) with two
disulﬁde bridges (Cys40/Cys132 and Cys89/Cys178) [5,6].
Comparison of the receptor-bound and free IL-22 structures
reveals that the largest main chain deviations are observed
for residues located in the pre-A and A helices region
(Asp43–Phe57), and in the AB loop (Asn68–Arg73) (Fig.
2A). The superposition of monomers A and B observed in
the asymmetric unit of free hIL-22 X-ray structure (PDB code
1M4R, [5]) onto receptor-bound IL-22 yielded r.m.s. devia-
tions of 0.41 and 0.72 A˚ for 118 and 120 pairs of Ca atoms,
respectively.
The extracellular IL-22R1 chain presents two FBN-III type
domains in tandem. Each FBN-III domain contains a sand-
wich of two anti-parallel b-sheets comprising seven b-strands
(A, B, E and C, C 0, F, and G), and these two FBN-III domains
are connected by a small helix extending from Ser114 to
His118. The N-terminal domain (D1) and the C-terminal do-main (D2) display a slightly larger inter-domain angle than
that observed in the IL-10R1 receptor chain. In IL-22R1, the
angle between residues Thr120, Thr48, and Glu196 is 121,
while the structural equivalent residues Thr103, Gln30, and
Gly178 in IL-10R1 form an angle of 115. Despite the diﬀer-
ence observed in inter-domain angles between IL-10R1 and
IL-22R1, the latter contacts IL-22 using ﬁve receptor binding
loops (L2–L6), as observed for the IL-10/IL-10R1 complex
[18]. The AB loop and the helix F interact with the receptor
loops L2–L4, and the N-terminus of helix A makes contacts
with the receptor loops L5–L6 of D2 domain (Fig. 2A).
The topology and the secondary structure organization of
IL-22R1 and IL-10R1 are very similar, but in the IL-22R1
N-terminal there is a small helix (Pro21–Leu24) which is ab-
sent in IL-10R1 structure. Moreover, two disulﬁde bonds pres-
ent in IL-10R1 (Cys35/Cys54 and Cys181/Cys202) are not
structurally equivalent to those found in the IL-22R1
(Cys71/Cys79 and Cys128/Cys217) (Fig. 1B). In the IL-22R1,
the ﬁrst disulﬁde bond connects Cys71 (on b-strand C 0) with
Cys79 (on b-strand E) in the D1 domain, and the second links
b-strand A (Cys128) to b-strand G (Cys217) in the D2 domain.
On the other hand, there is a counterpart of IL-22R1 Cys71/
Cys79 connectivity to the Cys49/Cys57 disulﬁde bridge present
in the extracellular domain of human tissue factor (PDB acces-
sion code 1TFH).
Fig. 2. Three-dimensional structure of IL-22/IL-22R1 complex determined by X-ray crystallography. (A) Ribbon representation of the IL-22/IL-
22R1 complex, showing the IL-22 molecule (in yellow) and the IL-22R1 extracellular domain (in red). Stereo view of IL-22/IL-22R1 binding
interface, showing contacts between IL-22 and IL-22R1 ﬁbronectin-III D1 (B) and D2 (C) domains. Disulﬁde bridges are shown in cyan, water
molecules are green, and intermolecular hydrogen bonds are shown as dotted lines.
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Comparative analysis of the IL-22/IL-22R1 and IL-10/IL-
10R1 interfaces indicates that the binding regions of both com-
plexes are grossly similar, but diﬀer in details. Most of the
residues present in the IL-22/IL-22R1 binding interface are
polar residues that establish an extensive network of hydrogen
bonds between IL-22 and the receptor loops. Moreover, the
presence of water molecules in the binding interface might be
involved in the IL-22/IL-22R1 complex stabilization.
The formation of the IL-22/IL-22R1 complex buries 828 A˚2
of IL-22 and 886 A˚2 of IL-22R1 solvent-accessible areas, and a
total of 25 amino acid residues are involved in the IL-22/IL-
22R1 binding interface ( Fig. 2B and C). IL-22R1 contacts
IL-22 residues situated on pre-helix A (Phe47, Gln49), helixA (Thr53, Ser64), the AB loop (Asp67, Thr70, Asp71,
Arg73), and helix F (Lys162, Gly165, Glu166, Asp168,
Arg175). The most important residues of IL-22R1 involved
in the binding interface are located on the receptor loops
L2–L6: Lys58, Tyr60, Gly61, Glu62, Leu88, Thr89, Glu90,
Tyr93, Arg112, Ser114, Pro206, and Thr207.
Each FBN-III domain of IL-22R1 shows direct and water-
mediated interactions with IL-22 (Table 2). At the N-terminal
FBN-III domain (D1 domain), the hydroxyl group of Tyr60
makes direct contacts with IL-22 Lys162 and Glu166 residues,
which are part of the IL-10 signature (162KAIGELDLL) situ-
ated at the beginning of helix F. Besides, the backbone oxygen
of Tyr60 interacts with the side chain of IL-22 Arg73 through a
water molecule (w4), and the Arg73 side chain is also hydrogen
Fig. 2 (continued )
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oxygen of Thr89 from IL-22R1. The IL-22 Arg73 residue is lo-Table 2
Water mediated interactions in the IL-22/IL-22R1 interface
IL-22 Water mediated interactions
Region Residue Atom Distance (A˚) Water
Pre-A Phe47 O 3.1 w9
Pre-A Phe47 O 2.6 w10
Pre-A Gln49 O 3.2 w9
Helix A Thr53 OG 2.9 w9
Helix A Thr53 OG 2.7 w10
Helix A Ser64 O 2.8 w3
AB loop Asp67 O 2.9 w3
AB loop Arg73 NH1 2.9 w4
AB loop Arg73 N 2.9 w5
AB loop Arg73 NH2 2.9 w6–w7
AB loop Arg73 NH2 2.9 w6–w7
AB loop Arg73 NH1 2.9 w4
Helix F Lys162 O 2.8 w8
Helix F Lys162 O 2.8 w8
Helix F Gly165 O 3.2 w1
Helix F Asp168 OD1 2.9 w1
Helix F Asp168 OD2 2.9 w2cated on the AB loop, together with Asp67 and Asp71 residues
that interact with Arg112 and Gly61 residues of IL-22R1,IL-22R1
Distance (A˚) Atom Residue Region
2.9 O Pro206 L6
2.7 O Thr207 L6
2.8 O Pro206 L6
2.8 O Pro206 L6
2.7 O Thr207 L6
2.5 OH Tyr93 L3
2.5 OH Tyr93 L3
2.7 O Tyr60 L2
2.7 O Gly61 L2
2.8 O Leu88 L3
2.7 O Glu90 L3
2.6 OE1 Glu90 L3
2.9 NH1 Arg112 L4
2.9 NH2 Arg112 L4
2.8 NH1 Arg112 L4
2.8 NH1 Arg112 L4
2.8 OG Ser114 L4
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IL-22 Thr70 residue, which is also hydrogen bonded to IL-
22R1 Lys58, and the Arg112 side chain interacts with
Gly165 and contacts Asp168 through a water molecule (w1)
(Fig. 2B).
Among these interactions found in the IL-22/IL-22R1 bind-
ing interface, there are three salt bridges (Asp71/Lys58, Asp67/
Arg112, and Arg73/Glu90), and also four additional contacts,
which are also conserved, in the IL-10/IL-10R1 complex
(Glu166/Tyr60, Asp71/Gly61, Gly165/Arg112, and Asp168/
Arg112 – IL-22/IL-22R1 numbering) (Fig. 2B). However, there
are two salt bridges in the IL-10/IL-10R1 complex that are not
conserved in the IL-22/IL-22R1 binding interface. The ﬁrst one
involves IL-10 Asp162 and IL-10R1 Arg117 residues, which
are equivalent to IL-22 Asp168 and IL-22R1 Arg112, respec-
tively. Our X-ray structure of IL22/IL-22R1 reveals that
Asp168 and Arg112 are not oriented to each other and they
present a water mediated interaction (w1). Besides, in the IL-
10/IL-10R1 heterodimer, Asp62 and Arg97 residues form a
salt bridge, but their corresponding residues Thr70 and
Tyr93 do not interact with each other in the IL-22/IL-22R1
complex.
At the C-terminal FBN-III domain of IL-22R1 (D2 do-
main), the backbone oxygen of IL-22R1 Thr207 interacts with
both Phe47 and Thr53 residues from IL-22 through a water
molecule (w10), and the Oc1 side chain of Thr207 residue
makes a direct contact with Ne atom of Arg175 located on
the IL-22 helix F. Moreover, the backbone oxygen of Pro206
from IL-22R1 forms interactions with IL-22 Phe47, Gln49,
and Thr53 residues mediated by a water molecule (w9) (Fig.
2C). The positions of Phe47 and Arg175 residues in the IL-
22 structure alone are diﬀerent from their positions in the
IL-22/IL-22R1 complex, indicating that there is a conforma-
tional change in the N-terminal region of IL-22 helix A upon
IL-22R1 binding.Fig. 3. The inﬂuence of IL-22R1 mutants in the IL-22 binding. (A)
Ribbon representation of the IL-22/IL-22R1 interface, showing IL-
22R1 Lys58 and Tyr60 residues and their IL-22 contact residues
(residues are colored as described in previous ﬁgure). (B) STAT
activation by IL-22R1 mutants: 105 HEK-293 cells were seeded in 48-
well plates, and cells were transfected with the indicated receptor
mutants, together with the STAT-dependent pGL3-Pap1-Luc and the
constitutive pRL-TK reporter plasmids. Cells were stimulated with IL-
22 or with control medium for 16 h, before a luciferase assay was
performed. The experiments were repeated at least ﬁve times in
duplicate with similar results.3.4. Structure-based site-directed mutagenesis studies reveal
functionally important residues at the IL-22R1 interface
To pinpoint the hot spots of interaction between IL-22 and
IL-22R1, we mutated key amino acid residues at the interface
of complex. The IL-22R1 Tyr60 side chain is hydrogen bonded
to both Lys162 and Glu166 residues of IL-22 at the interface
(Fig. 3A). These interactions have their counterparts in IL-
10/IL-10R1 complex, where IL-10R1 Tyr64 form hydrogen
bonds with IL-10 Lys156 and Glu160 side chains. In order
to check the importance of Tyr60 residue for IL-22/IL-22R1
binding, IL-22R1 Tyr60 residue was mutated to either an
Arg or Ala residue. Both Y60R and Y60A mutants did not af-
fect IL-22R1 cell surface expression, assessed by ﬂuorescent
automatic cell sorter analysis (data not shown). In order to as-
sess the functional role of IL-22R1 Tyr60 point mutants,
STAT3 dependent luciferase reporter gene assays were per-
formed in HEK-293 cells transiently transfected with wild type
or mutated IL-22R1 cDNAs. Wild type IL-22R1 transfections
showed clear functional response. By contrast, HEK-293 cells
transfected with IL-22R1 Y60R or Y60A mutants completely
failed to respond to IL-22, demonstrating that Tyr60 is a crit-
ical IL-22R1 residue for IL-22 binding (Fig. 3B).
A similar mutagenesis strategy was used to assess the impor-
tance of the interaction between Lys58 of IL-22R1 with IL-22
(Fig. 3A). When Lys58 was mutated into a negatively chargedresidue such as Glu, IL-22R1 could not be detected at the cell
surface (data not shown), suggesting that K58E point muta-
tion does not allow a normal protein folding, and cell surface
expression. However, the mutation of Lys58 to an Ala residue
did not aﬀect IL-22R1 cell surface expression, which allowed
us to assess its functional role in IL-22 activity. As shown in
Fig. 3B, the IL-22R1 K58A mutant was still capable to medi-
ate an IL-22 response, but with a 100-fold drop in speciﬁc
activity, reﬂecting its importance in the IL-22/IL-22R1 bind-
ing.
3.5. The IL-22/IL-22R1/IL-10R2 ternary complex model
Very recently, three ternary complexes have been published:
IL-4/IL-4 receptor a common c chain (cc) (IL-4Ra/cc), IL-4/
interleukin-13 receptor a (IL-13Ra1)/IL-4Ra and IL-13/IL-
Fig. 4. The IL-22/IL-22R1/IL-10R2 ternary complex model. Stereo view of the IL-22/IL-22R1 complex (IL-22 is shown in yellow, IL-22R1 is
marked in red) as superposed to the IL-4/IL-4Ra/cc (green, purple, and blue, respectively). The residues identiﬁed by Logsdon and co-workers as a
‘‘hot spot’’ for IL-10R2 binding are shown as an orange mesh.
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tively) [24]. The superposition of IL-22 from our IL-22/IL-
22R1 crystal structure onto IL-4 and IL-13-receptor complexes
reveals that IL-4/IL-4Ra/cc is a plausible model for IL-22/IL-
22R1/IL-10R2 ternary complex, where cc occupies a similar
position to IL-22R1 and IL-4Ra occupies a similar position
to IL-10R2 (Fig. 4).
We speculate that in the putative IL-22/IL-22R1/IL-10R2
complex model, the IL-22R1 and IL-10R2 interact with each
other via their D2 domains, and the IL-22 molecule interacts
with both receptor chains through distinct binding sites. The
IL-22R1 binding site includes IL-22 residues located on helix
A, the AB loop and helix F, while the IL-10R2 binding site
is formed by helices A and D that contains ﬁve hot spot resi-
dues for IL-10R2 binding (Tyr51, Asn54, Arg55, Tyr114,
and Glu117), which were identiﬁed by alanine scanning muta-
genesis assays [25].
It has been shown that IL-22 ﬁrst binds to the IL-22R1
extracellular domain with high aﬃnity, and the IL-10R2
sequentially recognizes and binds to the IL-22/IL-22R1 binary
complex [10]. The IL-22/IL-22R1 interactions induce confor-
mational changes in IL-22R1 and/or IL-22 and create a surface
binding site for IL-10R2, which is composed by IL-22 hot spot
residues and IL-22R1 FBN-III D2 domain (residues 174–190).
Functionally, after IL-10R2 binding to the IL-22/IL-22R1
complex, the ternary complex activates the JAK/STAT signal-
ing pathway what leads to diverse biological eﬀects related to
IL-22 [7,8].
Although proposed IL-22 ternary complex architecture
seems to be consistent with the available structural and func-
tional data, this putative model should be challenged by fur-
ther structural and functional studies.3.6. Protein data bank accession code
Atomic coordinates and structure factors of IL22/IL-22R1
complex have been deposited in the Protein Data Bank under
accession code 3DLQ.
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